Oct 31, 2019
Dr. Guy Chamberland, CEO, Tetra Bio-Pharma discusses why Tetra is focusing on developing cannabinoid-based therapies to help relieve chronic and breakthrough pain in patients with advanced cancers. He also speaks to how important it is to shorten the time to pain relief for those who are suffering. In the current...
Oct 31, 2019
Dr. Guy Chamberland, CEO, Tetra Bio-Pharma discusses why Tetra is focusing on developing cannabinoid-based therapies to help relieve chronic and breakthrough pain in patients with advanced cancers. He also speaks to how important it is to shorten the time to pain relief for those who are suffering. In the current...
Oct 22, 2019
Dale Gieringer, Director, California NORML talks about some of the many reasons there has not been more research done on the uses for cannabis to treat a wide variety of diseases and chronic conditions. We met at the recent 2nd Annual Cannabis and Health Symposium a gathering of researchers and other stakeholders...
Oct 22, 2019
Dale Gieringer, Director, California NORML talks about some of the many reasons there has not been more research done on the uses for cannabis to treat a wide variety of diseases and chronic conditions. We met at the recent 2nd Annual Cannabis and Health Symposium a gathering of researchers and other stakeholders...
Oct 17, 2019
Jenna Balestrini is Head of Cell Bioprocessing and Precision Medicine at Draper, the not-for-profit MIT spin-off engineering lab. Working with scientists and engineers, Jenna describes their efforts addressing the time and costs related to immunotherapy treatments by looking at manufacturing limitations, applying new...